Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
3176
PUT
Novo Nordisk
NVO
$205B
| $721K | ﹤0.01% |
27,200
+20,000
| +278% | +$461K |
|
|
QEPM
3177
DELISTED
QEP MIDSTREAM PARTNERS LP UIT REPSTG LTD PARTSP INT (DE)
QEPM
| $721K | ﹤0.01% |
+48,094
| New | +$765K |
|
3178
Dillards
DDS
$9.59B
| $720K | ﹤0.01% |
5,289
-26,539
| -83% | -$3.31M |
|
3179
CALL
iShares Core S&P Small-Cap ETF
IJR
$113B
| $720K | ﹤0.01% |
12,200
-49,600
| -80% | -$2.84M |
|
3180
iShares MSCI Hong Kong ETF
EWH
$1.21B
| $719K | ﹤0.01% |
34,199
-22,015
| -39% | -$472K |
|
3181
Willis Towers Watson
WTW
$31B
| $719K | ﹤0.01% |
5,657
-3,031
| -35% | -$372K |
|
3182
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $718K | ﹤0.01% |
39,445
+6,660
| +20% | +$121K |
|
3183
CACI
CACI
$14.8B
| $712K | ﹤0.01% |
7,998
-1,402
| -15% | -$122K |
|
3184
Rollins
ROL
$17.4B
| $712K | ﹤0.01% |
66,717
-16,072
| -19% | -$162K |
|
3185
PUT
Intuit
INTU
$98B
| $710K | ﹤0.01% |
7,400
-600
| -8% | -$55.7K |
|
3186
Accuray
ARAY
$32.9M
| $707K | ﹤0.01% |
78,540
+74,168
| +1,696% | +$590K |
|
|
CA
3187
CALL
DELISTED
CA, Inc.
CA
| $707K | ﹤0.01% |
22,100
-15,500
| -41% | -$491K |
|
3188
PUT
DaVita
DVA
$11.4B
| $705K | ﹤0.01% |
8,700
-204,600
| -96% | -$15.7M |
|
|
NUAN
3189
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $704K | ﹤0.01% |
58,097
-98,406
| -63% | -$1.19M |
|
3190
Enpro
NPO
$7.12B
| $703K | ﹤0.01% |
10,807
+1,347
| +14% | +$86.2K |
|
|
CIE
3191
CALL
DELISTED
Cobalt International Energy, Inc
CIE
| $703K | ﹤0.01% |
5,207
+2,960
| +132% | +$400K |
|
3192
Grand Canyon Education
LOPE
$3.79B
| $702K | ﹤0.01% |
16,329
-7,497
| -31% | -$336K |
|
3193
PUT
Becton Dickinson
BDX
$49.6B
| $701K | ﹤0.01% |
5,023
-83,742
| -94% | -$11.7M |
|
3194
PUT
Ventas
VTR
$46.3B
| $701K | ﹤0.01% |
8,407
-3,765
| -31% | -$324K |
|
3195
PUT
Canadian National Railway
CNI
$77.2B
| $700K | ﹤0.01% |
10,600
-25,100
| -70% | -$1.71M |
|
|
AMPE
3196
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $700K | ﹤0.01% |
+333
| New | +$568K |
|
|
BRLI
3197
PUT
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $700K | ﹤0.01% |
20,000
-52,100
| -72% | -$1.76M |
|
|
CDK
3198
CALL
DELISTED
CDK Global, Inc.
CDK
| $699K | ﹤0.01% |
15,200
+13,770
| +963% | +$628K |
|
3199
CALL
Boston Scientific
BSX
$74.9B
| $697K | ﹤0.01% |
41,000
+5,300
| +15% | +$83.8K |
|
3200
PUT
AvalonBay Communities
AVB
$26.3B
| $696K | ﹤0.01% |
4,000
+1,800
| +82% | +$311K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.